Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
While not always a complete disqualifier, patients who have a history of the following conditions should likely avoid Semaglutide: Multiple endocrine neoplasia syndrome type 2 (MEN2) Pancreatitis Gallbladder problems Thyroid cancer Type I diabetes History of severe symptoms of low blood sugar If a patient currently takes a GLP-1 medication, they may be able to switch to Semaglutide
The 0.5 mL syringe holds up to 50 units
All materials are intended strictly for laboratory research, analytical testing, and scientific investigation
Endocrinologists' Views on Tesofensine as a Treatment Option Endocrinologists, specializing in hormonal disorders and metabolic conditions, recognize the complexity of obesity and the need for effective treatment options
They will consider healing time, inflammation, risk of infection, and recovery time before starting the medication
